Barclays increased its price target for Quest Diagnostics (NYSE:DGX), indicating potential upside for the stock. The company reported robust second-quarter results with significant revenue gr...
Investment firm HSBC initiated a "Hold" ratin...
Rhinebeck Bancorp successfully completed its ...
Intel (NASDAQ: INTC) Soars on Strong Q1 Earnings and AI-Driven Growth Intel reported strong Q1 financial performance, with earnings per share (EPS) doubling analyst estimates. The company achieved si
Revenue Forecast: Charter Communications anticipates a 1.77% decline in Q2 2026 revenue, signaling potential challenges for the telecommunications giant. EPS Outlook: Despite revenue pressure
Leveraged exchange-traded funds (ETFs) and individual company stocks experienced significant declines due to various market pressures. Key drivers of the downturn included anticipation of earnings re
Market Movers: Analyzing Today's Top Stock Gainers and Their Drivers Strong financial results propelled NVE Corporation (NASDAQ: NVEC) to significant gains. Corporate actions, specifically reverse st
Jefferies analyst raised the Thermo Fisher Scientific price target to $630.00, suggesting a 10.02% upside. The company reported strong Q2 financial performance, with adjusted EPS of $6.03 and quarter
RBC Capital has raised its price target for Argenx to $1,025, maintaining an Outperform rating. The company reported robust Q2 product net sales of $1.5 billion, marking a 60% year-over-year
